Provided by Tiger Trade Technology Pte. Ltd.

Larimar Therapeutics, Inc.

4.30
-0.0800-1.83%
Volume:1.12M
Turnover:4.83M
Market Cap:447.20M
PE:-2.20
High:4.41
Open:4.40
Low:4.24
Close:4.38
52wk High:6.42
52wk Low:1.61
Shares:104.00M
Float Shares:73.66M
Volume Ratio:0.48
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9534
EPS(LYR):-1.3159
ROE:-78.24%
ROA:-42.99%
PB:3.22
PE(LYR):-3.27

Loading ...

Sep 29, 2020

Major Issues Report

8-K/A [Amend] - Current report
Sep 29, 2020

Major Issues Report

8-K - Current report
Aug 31, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 14, 2020

Major Issues Report

8-K/A [Amend] - Current report
Aug 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2020

Major Issues Report

8-K - Current report
Aug 06, 2020

Major Issues Report

8-K - Current report
Jul 13, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 01, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 30, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 26, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 26, 2020

Major Issues Report

8-K/A [Amend] - Current report
Jun 11, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 08, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 08, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 05, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2020

Major Issues Report

8-K - Current report
Jun 02, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2020

Correspondence

CORRESP [Cover] - Correspondence